Company Filing History:
3 out of 3,684 
3 out of 86 
Years Active: 2012-2013
Title: Greg Zipp: Innovator in G-Protein Coupled Receptor Research
Introduction: Greg Zipp, an accomplished inventor based in Robbinsville, NJ, has made significant contributions to the field of pharmaceutical research. With a total of three patents to his name, Zipp has focused on modulating specific receptor functions, which hold promise for various therapeutic applications.
Latest Patents: Among his notable patents, one stands out: the "Modulators of G protein-coupled receptor 88." This invention involves compounds capable of modulating the G-protein coupled receptor 88. The associated methods aim to use these compounds for developing innovative therapies, showcasing Zipp's commitment to advancing medical science.
Career Highlights: Greg Zipp has held key positions at prominent pharmaceutical companies, including Bristol-Myers Squibb Company and Lexicon Pharmaceuticals, Inc. His experiences in these organizations have honed his expertise in drug development and receptor modulation, subsequently leading to his innovative patent filings.
Collaborations: Throughout his career, Zipp has collaborated with distinguished colleagues, such as Yingzhi Bi and Carolyn Diane Dzierba. Their partnerships have played an essential role in the progress of his research and patents, reinforcing the importance of teamwork in advancing scientific discovery.
Conclusion: Greg Zipp's innovative work in the realm of G-protein coupled receptors demonstrates his dedication to developing new therapeutic strategies. His contributions, reflected in his patents and collaborations, pave the way for future advancements in pharmaceutical innovation. As a leading inventor, Zipp continues to influence the industry and inspire aspiring scientists.